Toggle Dropdown
Groups
Announcements
Projects
Ideas
Welcome guest
Log in
Practice
My Requests
All Requests
Drill Partners
Digital games
Projects
Goals
Loading
Loading...
0
0
Eli Lilly Surges 9% After Obliterating Forecasts As Mounjaro, Zepbound Sales Double - Investor's Business Daily
2/4/26 at 1:15pm
Organization
Investor's Business Daily
32 words
0
Comments
While Novo Nordisk is calling for a sales downfall in 2026, Eli Lilly is more upbeat.
Pharmaceuticals & Biotech
Business & Industrial
Company News
Financial Markets News
Stocks & Bonds
Drugs & Medications
You are the first to view
https://www.investors.com/news/technology/eli-lilly-stock-eli-lilly-earnings-q4-2025/
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...